Fortrea Holdings Inc.

NASDAQ:FTRE

Biotechnology

Healthcare
$20.50 -0.46%

-$0.07 today

Market cap
$1.94B
Beta
2.11
P/E (TTM)
-3.1
EPS (TTM)
-$4.90
52W Low $4.36High $18.67

Volume 1.59M

Average 1.31M

FTRE Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Fortrea Holdings Inc.NASDAQ: FTRE

Net Margin · Q2 FY2026 · quarter ended Jun 2026

Net margin widens to -1.9%

Net margin was -1.9% in Q2 FY2026, up 50.8 pp from a year earlier. On a trailing-twelve-month basis it was -3.2%, up 34.4 pp year over year. Over 3 fiscal years it narrowed by 42.8 pp.

Context

  • Net margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 9 analysts of 2.9% for the fiscal year ending Dec 2026, up from -36.2% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
-1.9%+1.8 pp QoQ
Last fiscal yearDec 2025
-36.2%-24.0 pp YoY
LTMJun 2026
-3.2%+34.4 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+50.8 pp+5.5 pp-45.3 pp
1 year-24.0 pp+39.1 pp+63.2 pp
3 years-42.8 pp+41.2 pp+83.9 pp
5 years+42.3 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
-36.2%
Year-over-year change
-24.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How FTRE compares with its peers on the latest reported figures

  • FTRE's LTM Jun 2026 net margin of -3.2% is the 2nd highest of the 3 companies compared; the peer median is 7.3%.
  • Its year-over-year change of +34.4 pp is the highest of 3, against a peer median of -1.5 pp.
  • Over three fiscal years its change of -42.8 pp compares with a peer median of -1.9 pp.
FTRE Competitors Peer median
Net Margin for FTRE and competitors
Company Period LTM level YoY 3-year change
MEDPMedpace Holdings, Inc.LTM Sep 202618.2% -0.1 pp+1.0 pp
FTREFortrea Holdings Inc.LTM Jun 2026-3.2% +34.4 pp-42.8 pp
CERTCertara, Inc.LTM Mar 2026-3.6% -2.9 pp-4.8 pp
Peer median (excluding FTRE) 7.3%-1.5 pp-1.9 pp

Competitors are the stored peer set for FTRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.06B2.84B2.84B2.7B2.72B
Cost of Revenue2.45B2.11B2.25B2.16B2.3B
Gross Profit604.4M724.4M590.6M534.2M425.8M
Gross Margin19.8%25.5%20.8%19.8%15.6%
Research & Development00000
Selling, General & Admin303.1M416.1M448.1M560.7M456.4M
Operating Expenses490.1M537.3M558.6M696.1M456.4M
Depreciation & Amortization166.3M93.6M98M86.9M78M
EBITDA302.9M280.8M137.2M(64.3M)(813.6M)
EBITDA Margin9.9%9.9%4.8%-2.4%-29.9%
Operating Income114.3M187.1M32M(161.9M)(30.6M)
Operating Margin3.7%6.6%1.1%-6.0%-1.1%
Interest Income00000
Interest Expense200K200K69.8M123.8M91.4M
Other Income / Expenses22.1M(100K)(62.5M)(113.1M)(952.4M)
Income Before Tax136.4M187M(30.5M)(275M)(983M)
Pre-Tax Margin4.5%6.6%-1.1%-10.2%-36.1%
Income Tax Expense38.4M41.1M1.2M(3.5M)3.2M
Net Income98M186.2M(25.2M)(328.5M)(986.2M)
Net Margin3.2%6.6%-0.9%-12.2%-36.2%
EPS (Basic)1.112.11(0.04)(3.67)(10.81)
EPS (Diluted)1.112.11(0.04)(3.67)(10.81)
Weighted Avg Shares88.4M88.4M88.8M89.5M91.2M
Weighted Avg Shares (Diluted)88.4M88.4M88.8M89.5M91.2M

Fortrea Holdings Inc.

NASDAQ:FTRE

Intrinsic Alpha fair value

Locked

Current Price

$20.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.